5.54
5.54 (0%)
As of Apr 17, 2025
Cryoport, Inc. [CYRX]
Source:
Company Overview
Cryoport Inc is a global leader in integrated temperature-controlled supply chain solutions for the life sciences industry, with a strong focus on supporting the Cell and Gene Therapy market (CGT).
| Country | United States |
| Headquarters | brentwood, tennessee |
| Phone Number | (949) 470-2300 |
| Industry | manufacturing |
| CEO | Jerrell W. Shelton |
| Website | www.cryoportinc.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $228.4 |
| Operating Profit | $-130.9 |
| Net Income | $-114.8 |
| Net Cash | $-1.1 |
Profit Ratios
| Gross Margin | $99.6 |
| Operating Margin | -57.3 |
| Profit as % of Revenues | -86.8% |
| Profit as % of Assets | -13.8% |
| Profit as % of Stockholder Equity | -28.6% |
Management Effectiveness
| Return on Equity | -28.6% |
| Return on Assets | -16.3% |
| Turnover Ratio | 27.5% |
| EBITA | $-130.9 |
Balance Sheet and Cash Flow Measures
| Total Assets | $703.5 |
| Total Liabilities | $301.6 |
| Operating Cash Flow | $-16.3 |
| Investing Cash Flow | $176.8 |
| Financing Cash Flow | $-161.5 |
